Journal article icon

Journal article

Charting and Sidestepping the Pitfalls of Disproportionality Analysis

Abstract:
Disproportionality analysis is used by many pharmacovigilance organizations for detecting and assessing signals of potential adverse drug reactions. However, its goal is often misunderstood and the approach misapplied, leading to erroneous conclusions due to neglected violated assumptions. In this paper we illustrate how simplistic use and interpretation of disproportionality analysis can lead to incorrect conclusions. Using VigiBase, the WHO global database of adverse event reports, and the Information Component disproportionality metric, we provide selected examples to highlight common sources of error that can introduce spurious disproportionalities or lead to missing important signals: confounding (by age, sex, indication, comedication), effect modification (by age), notoriety bias, masking, misclassification (by miscoding, incomplete or imprecise event retrieval), neglecting report utility, and violated independence assumption. Additionally, we present how sophisticated analyses may introduce new biases or amplify existing ones, such as collider bias or masking amplification. Due to its pitfalls, disproportionality analysis plays a supportive rather than decisive role in signal detection and assessment. Careful design and interpretation of disproportionality analysis, with appropriate subgrouping and clinical assessment, are essential. While subgrouping can mitigate some pitfalls, it reduces sample size and may introduce or amplify existing biases and needs to be used with care. Further development of tools to detect and mitigate biases in disproportionality analyses, and to assess their risk of bias, is needed.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1007/s40264-025-01604-y

Authors

More by this author
Role:
Author
ORCID:
0000-0002-0254-2212
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-3634-0317
More by this author
Role:
Author
ORCID:
0000-0002-2236-1398
More by this author
Role:
Author
ORCID:
0000-0002-4595-230X


Publisher:
Springer
Journal:
Drug Safety: The Official Journal of the International Society of Pharmacovigilance More from this journal
Volume:
49
Issue:
2
Pages:
147-162
Publication date:
2025-09-24
DOI:
EISSN:
1179-1942
ISSN:
0114-5916


Language:
English
Keywords:
Pubs id:
2417958
Local pid:
pubs:2417958
Source identifiers:
W4414462459
Deposit date:
2026-05-10
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP